FELLSIDE THERAPIES CIC

Company limited by guarantee

Company Registration Number:
09415363 (England and Wales)

Unaudited statutory accounts for the year ended 1 February 2025

Period of accounts

Start date: 2 February 2024

End date: 1 February 2025

FELLSIDE THERAPIES CIC

Contents of the Financial Statements

for the Period Ended 1 February 2025

Profit and loss
Balance sheet
Additional notes
Community Interest Report

FELLSIDE THERAPIES CIC

Profit And Loss Account

for the Period Ended 1 February 2025

2025 2024


£

£
Turnover: 3,860 2,850
Cost of sales: 0 0
Gross profit(or loss): 3,860 2,850
Distribution costs: 0 0
Administrative expenses: ( 3,886 ) ( 2,995 )
Other operating income: 0 0
Operating profit(or loss): (26) (145)
Interest receivable and similar income: 0 0
Interest payable and similar charges: 0 0
Profit(or loss) before tax: (26) (145)
Tax: 0 0
Profit(or loss) for the financial year: (26) (145)

FELLSIDE THERAPIES CIC

Balance sheet

As at 1 February 2025

Notes 2025 2024


£

£
Fixed assets
Intangible assets:   0 0
Tangible assets:   0 0
Investments:   0 0
Total fixed assets: 0 0
Current assets
Stocks:   0 0
Debtors:   0 0
Cash at bank and in hand: 3,860 2,850
Investments:   0 0
Total current assets: 3,860 2,850
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year:   0 0
Net current assets (liabilities): 3,860 2,850
Total assets less current liabilities: 3,860 2,850
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Accruals and deferred income: 0 0
Total net assets (liabilities): 3,860 2,850
Members' funds
Profit and loss account: 3,860 2,850
Total members' funds: 3,860 2,850

The notes form part of these financial statements

FELLSIDE THERAPIES CIC

Balance sheet statements

For the year ending 1 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 19 June 2025
and signed on behalf of the board by:

Name: Julie Price
Status: Director

The notes form part of these financial statements

FELLSIDE THERAPIES CIC

Notes to the Financial Statements

for the Period Ended 1 February 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

FELLSIDE THERAPIES CIC

Notes to the Financial Statements

for the Period Ended 1 February 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 0 0

COMMUNITY INTEREST ANNUAL REPORT

FELLSIDE THERAPIES CIC

Company Number: 09415363 (England and Wales)

Year Ending: 1 February 2025

Company activities and impact

The company provides people in the Eden Valley and elsewhere in northern England, in particular people with mental health issues and their families, friends and supporters with - counselling and therapy services - other wellbeing oriented services and activities - increased awareness of mental health issues. During the financial year 2024–2025, the company has provided benefits to the community in the following ways - residents have been able to access local counselling services - patients from two GP surgeries in the Eden Valley received mental health support during breathing workshops - individuals have received confidential advice on mental health awareness.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
19 June 2025

And signed on behalf of the board by:
Name: Julie Price
Status: Director